Demonstration of Epstein-Barr virus antibodies in serum of patients with nasopharyngeal carcinoma

Indian Journal of Cancer

Volumn 38, Issue 2-4, 2001, Pages 72-75

  Kumar, S ^b   Wairagkar, N S ^a   Mahanta, J ^a  

^a REGIONAL MEDICAL RESEARCH CENTRE   (India)

^b NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ARTICLE; BLOOD; COMPARATIVE STUDY; EPIDEMIOLOGY; EPSTEIN BARR VIRUS; HUMAN; IMMUNOLOGY; INDIA; ISOLATION AND PURIFICATION; NASOPHARYNX TUMOR; PREVALENCE; VIROLOGY; VIRUS INFECTION;

ANTIBODIES, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; INDIA; NASOPHARYNGEAL NEOPLASMS; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES;

EID: 0038389128     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Advani S.H., connelly R.R. and Ablash D.V.: Distribution of antibody to Epstein-Barr Virus among patients with haematologic malignancies. Indian J. Med. Res. 1988:87;240-245.
2. De The G., Geser A., Day N.E., Tukas P.M., Williams E.H., Beri D.P., Smith P.G., Don A.G., Brokmamn G.W., Ferino P. and Henle W.: Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugadan prospective study. Nature, 1978:247; 756-758.
3. Epstein M.A. and Achang B.G.: Introduction: Discovery and general biology of the virus in "The Epstein Barr Virus (Eds) M.A. Epstein and B.G. Achang, Spinger, Berlin Heidelberg, New York, 1979:1-22.
4. Ganzer U: Nasopharyngeal carcinoma: Remarks on etiology, diagnosis and prognosis. Strahlentherapie Onkol. 1987: 163;519-524.
5. Henle G. and Henle W.: Epstein Barr Virus specific IgA serum antibodies as an outstanding feature of nasophynyngeal carcinoma. Int. J. Cancer. 1976:17;1-7.
6. Henderson E.E.: Physico-chemical viral synergism during Epstein Barr Virus infection: A review. J. Natl. Cancer Inst. 1988: 80;476-483.
7. Ho J.H.C., Kwan H.C., Ng M.H. and de The G: Serum IgA antibodies to Epstein Barr Virus capsid antigen. Lancet. 1978:1;437-438.
8. John T.J.: Sero epidemiology of herpes viruses in vellore. Virus Informmation Exchange News Letter for South East Asia and Western Pacific. 1984:I; 26.
9. Kumar S., Zinyu R., Chetia M. and dutta L.P.: Genotoxic effect of smoke dried meat extract in Swiss albino mice using sperm head shape abnormality test Cancer Letter 1992:64;51-53.
10. Kumar S., Zinyu R., Singh I.K.K., Medhi S.B., Baruah T., Das B. and Dutta L.P.: Studies on nasopharyngeal carcinoma in North Eastern Region of India. Aan Natl Acad-Med. Sci, 1996:32; 199-208.
11. Melbye M., Ebbersen P., Levine P.H. and Bennike T.: Early primary infection and high Epstein Barr Virus antibody titer in Greenland Eskimos at high risk for nasopharyngeal carcinoma. Int. J. Cancer 1984: 34;619-623.
12. Oberender H., Nowak R., Donvier A., Brichacek E., Venka V., Tetrin W., Kankel N.: EBV specific antibodies in patients with nasopharyngeal carcinoma and tonsillar carcinoma (a four year follow up) Laryngorhinootologic 1989: 68;181-185.
13. Poirier S., Ohshima H., de The G., Hubert A., Bourgade H.C. and Bertsch H.: Volatile nitrosamins levels in common foods from Tunisia, South China and Greenland, high risk area for nasopharyngeal carcinoma (NPC). Int. J. Cancer. 1989 : 39;293-296.
14. Reedman B.M. and Klein G.: Cellular localization of an Epstein Barr Virus (EBV) associated compliment fixing antigen in producer and nonproducer lymphoblastoid cell lines. Int. J. Cancer. 1973: 11;499-520.
15. Sarkar S., Nagabhushan M., Soman C.S., Tricker A.R. and Bhide S.V.: Mutagenicity and carcinogenicity of smoked meat from Nagaland, a region of India prone to a high incidence of nasopharyngeal cancer. Carcinogenesis, 1989: 10;733-736.